Research and development consulting
The R&D practice helps life science and pharma clients identify and validate biological and disease targets critical to drug and diagnostic development.
This includes drug discovery, preclinical, clinical, proof-of-concept, and regulatory activities by providing data and knowledge across the drug discovery and development spectrum. By providing perspective, data and insights garnered through 30+ years of industry leadership., we complement client teams in generating long term value.
Our R&D team is also home to the Centre for Medicine Research (CMR) a highly reputable source of pharmaceutical industry metrics and insights.
Areas of expertise
We work with companies to accelerate drug discovery, preclinical/clinical, proof-of-concept, and regulatory activities by providing strategic insights and actionable data across the discovery and development spectrum.
We take pride in advancing our client’s research programs and gaining new biological insights by answering complex research questions. Our team of PhD-level experts accelerates drug discovery using cutting-edge methods, artificial intelligence and comprehensive data analysis. We offer flexible engagement models, from hourly consultations to full-time support ensuring tailored solutions for every need. Through transparent communication and rigorous research, we efficiently drive our clients’ programs towards success.
We partner with our clients to:
- Unlock New Therapeutic Pathways: Biological mechanism elucidation
- Enhance Patient Outcomes: Biomarker discovery and patient stratification
- Optimize Treatment Strategies: Drug response and drug combination research
- Advance Cancer Research: Immuno-oncology expertise
- Revitalize Existing Assets: Target identification and drug repurposing
- Maximize ROI: Indication prioritization
- Streamline Analysis: Custom pipeline and applications development
- Uncover Hidden Insights: Comprehensive data mining and integration
- Reveal Complex Biology Connections: Multi-omics analysis (genomics, proteomics, single-cell, spatial, microbiome, etc.)
- Computational Biology for Drug Discovery (CBDD): consortium for selection and uniform implementation of algorithms for drug discovery and development
Our highly experienced Regulatory & Clinical team of international experts is dedicated to empowering you to stay ahead of compliance risks, accelerate your pipeline, equip you with actionable competitive intelligence and build robust regulatory strategies using data and a deep understanding of legislation and guidance. Our global experts support your journey of understanding and navigating of the ever-dynamic regulatory environment across 200+ markets in the areas of small molecules, biologics, medical devices, in vitro diagnostics, combination products, cosmetics, food supplements and veterinary products. Our Consulting team sits at the center of our unique combination of deep industry expertise, high-quality data, and innovative technology applications.
Offerings include:
- Regulatory intelligence customized solutions across 200+ markets for Pharma, Biotech, MedTech, Consumer Health, Animal Health and Digital Health industries.
- Regulatory strategy assessments to understand the submission process and requirements for each market and product to better plan market launch.
- Regulatory and clinical landscape and precedence to understand specific requirements that may have a direct impact on new submissions as well as supporting evidence for new claims and indications.
- Competitive intelligence monitoring to analyze competitor data for key products and indications through all development stages from clinical trials to regulatory approvals.
- Regulatory, Pharmacovigilance, CMC, OTC and GxP monitoring newsletters and dashboards including visualization and navigation features such as charts and heatmaps.
- GxP compliance including customized workshops with Subject Matter Experts, Quality Management System audits to analyze current workflows and propose improvement and remediation actions, as well as Standard Operating Procedure writing.
- Regulatory and Clinical writing, including customized expert reports, clinical evaluation reports and thought leadership pieces.
- Workflow-based technology solutions in conjunction with our Technology experts, supporting from scoping and design through testing, training, and implementation processes.
The Centre for Medicines Research (CMR) International, is a leader in biopharmaceutical R&D performance analytics. For over 25 years, CMR has worked with the leading global biopharmaceutical companies to assess R&D and Clinical productivity and provide actionable data and insights.
CMR’s performance analytics programmes have been the gold standard for collecting and reporting R&D operations. Data are collected directly from participating biopharmaceutical companies, validated, standardised, and combined into a large, blinded reporting database. The datasets apply unique depth and historical context to uncover reliable industry trends.
Offerings include:
-
R&D & Clinical Performance Metrics Programs
-
Pharmaceutical R&D Factbook & Pharmaceutical Clinical Factbook
-
Consulting services providing actionable and strategic insights
New services for 2025
Regulatory Strategy Assessment
“I am developing a new product and I need to understand the regulatory requirements to launch it across international markets.”
Clinical Trial Optimization
Determine the right design to optimize efficiency and efficacy for your clinical trial.
53% of all trials need to amend their protocols after initiation due to sub-optimal protocols.
Multi-omics integration with RWD
Expand indication space for your asset considering biological mechanism, competitive landscape and epidemiology of the disease.
We apply advanced AI to Clarivate proprietary datasets spanning the entire Drug Development lifecycle.
Knowledge Graphs
Integrate and analyze vast amounts of heterogeneous data to uncover hidden patterns and insights into biological systems and clinical data.
By applying AI to Knowledge Graphs, we enhance knowledge retrieval, visualization, and graph-based AI applications.
Biopharma R&D solutions
Pinpoint your ideal patient and address true patients’ needs through discovering and designing treatments with comprehensive scientific and clinical intelligence.
Our latest thought leadership
Innovative therapeutics: Challenges and opportunities in developing drug combinations
In the rapidly evolving field of medicine, developing new therapeutic strategies is crucial for addressing complex diseases that single-agent treatments often fail to manage effectively. This webinar will delve into the intricate landscape of combination drug therapy, exploring the scientific, regulatory, and commercial challenges involved, while also highlighting the significant potential for improved patient outcomes...
Best practices for AI and ML use across the drug discovery and development lifecycle
The speed of drug discovery and development are being transformed by AI and machine learning applications. AI and life science companies need to conduct due diligence to ensure optimal results and avoid the pitfalls of AI capabilities.
Unleashing the power of computational tools in rare disease
In the vast landscape of pharmaceutical innovation, few therapy areas present challenges and opportunities as compelling as those faced in rare disease. These conditions, affecting small patient populations and characterized…
